Xeris Biopharma Holdings

ISIN US98422E1038

WKN A3C4ZC

Market cap (in EUR)

1,316 m

Country

United States

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Show more Show less

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR	1,316 m
EPS, EUR	-0.09
P/B ratio	97.6
P/E ratio	123.8
Dividend yield	0.00%

Income statement (2025)

Revenue, EUR	259 m
Net income, EUR	0 m
Profit margin	0.19%

What ETF is Xeris Biopharma Holdings in?

There are 30 ETFs which contain Xeris Biopharma Holdings. All of these ETFs are listed in the table below. The ETF with the largest weighting of Xeris Biopharma Holdings is the L&G Pharma Breakthrough UCITS ETF.

ETF	Weight	Investment focus	Fund size (in m EUR)
iShares Russell 2000 Swap UCITS ETF USD (Acc)	0.03%	Equity United States Small Cap	56
Xtrackers MSCI World Small Cap UCITS ETF 1D	0.01%	Equity World Small Cap	12
L&G Russell 2000 US Small Cap Quality UCITS ETF	0.04%	Equity United States Small Cap	196
Amundi Russell 2000 UCITS ETF EUR (C)	0.03%	Equity United States Small Cap	801
iShares MSCI World Small Cap UCITS ETF	0.01%	Equity World Small Cap	7,842
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C	0.04%	Equity World Health Care Social/Environmental	24
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF EUR Hedged (Acc)	0.04%	Equity United States Small Cap	160
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist	0.03%	Equity United States Small Cap	3
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist)	0.01%	Equity World Small Cap	48
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD	0.04%	Equity United States Small Cap	4,999
WisdomTree Russell 2000	0.03%	Equity United States Small Cap	7
Xtrackers MSCI Global Social Fairness Contributors UCITS ETF 1C	0.01%	Equity World Social/Environmental	3
Amundi Russell 2000 UCITS ETF USD	0.03%	Equity United States Small Cap	224
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Acc)	0.00%	Equity World	7,188
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc	0.02%	Equity United States Small Cap	34
State Street SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Acc)	0.01%	Equity World Small Cap	1,762
Xtrackers Russell 2000 UCITS ETF 1C	0.03%	Equity United States Small Cap	2,650
State Street SPDR MSCI All Country World Investable Market UCITS ETF USD Unhedged (Dist)	0.00%	Equity World	204
Xtrackers MSCI Global SDGs UCITS ETF 1C	0.03%	Equity World Social/Environmental	7
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc)	0.01%	Equity United States Small Cap	2,935
Xtrackers MSCI World Small Cap UCITS ETF 1C	0.01%	Equity World Small Cap	142
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc	0.03%	Equity United States Small Cap	3
Invesco Nasdaq Biotech UCITS ETF	0.10%	Equity United States Health Care Biotech	404
iShares Russell 2000 Swap UCITS ETF EUR Hedged (Acc)	0.03%	Equity United States Small Cap	122
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.10%	Equity United States Health Care Biotech	67
Invesco Russell 2000 UCITS ETF	0.03%	Equity United States Small Cap	299
iShares Nasdaq US Biotechnology UCITS ETF	0.10%	Equity United States Health Care Biotech	924
State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF USD	0.00%	Equity United States Small Cap	976
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc	0.02%	Equity United States Small Cap	44
L&G Pharma Breakthrough UCITS ETF	3.16%	Equity World Health Care Innovation	20

Change your settings